Leah Suttner

Publications

146

Citations

H-Index

2016

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Erasmus MC

Johns Hopkins University

Wayne State University

Sidney Kimmel Comprehensive Cancer Center

Leah Suttner is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacotherapy, and magnetic resonance imaging.

Top concepts

MedicinePharmacotherapyUrologyOncologyNeurologyPathologyRadiologyImmunologyPsychiatryEngineering

Publications per year

2016–2024

Publications

No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals

Nicole B. Gabler, Naihua Duan, Eli Raneses et al. · Trials · 2016 · 39 citations · Full text

Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study

Xi Wang, Leah Suttner, Thomas Jemielita et al. · Journal of Biopharmaceutical Statistics · 2021 · 27 citations · Full text

Independent drug action and its statistical implications for development of combination therapies

Cong Chen, Fang Liu, Yixin Ren et al. · Contemporary Clinical Trials · 2020 · 18 citations

Drug Repositioning, Psychiatry, Statistical Implications +9

Biomarker analysis from the KEYNOTE-199 trial of pembrolizumab in patients (pts) with docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC).

Emmanuel S. Antonarakis, Jose M. Mateos Rodriguez, Marine Gross‐Goupil et al. · Journal of Clinical Oncology · 2020 · 14 citations

Median Cps, Immunology, Pathology +22

Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors

Anastasios Stathis, Anthony W. Tolcher, Judy S. Wang et al. · Investigational New Drugs · 2023 · 14 citations · Full text

Rows per page

1–5 of 8